Pharmanet into phase 1 clinical trials

WA-LISTED pharmaceutical group Pharmanet has announced that its subsidiary, Molecular Pharmacology Limited, has received approval for the commencement of human trials into the effectiveness of its Thermalife Cream and its analgesic and anti-inflammatory compound Tripeptofen.